Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma

NCT05561049 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Multiple Myeloma

Interventions

DRUG: Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens

Sponsor

The First Affiliated Hospital of Soochow University